Another significant probe was localized to A2BP1, which is a schizophrenia risk gene and reported to have a reduced expression in the cortical regions of schizophrenia patients (64) and genetic association with olanzapine-induced weight gain in the Chinese Han population (65), suggesting its involvement in both pathogenesis and treatment response. This evidence concerns the gene RBFOX1 and schizophrenia.